Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Mamma Screening

Between statistics and casuistry

    • Gynecology
    • News
    • Oncology
    • Prevention and health care
    • RX
  • 2 minute read

Once again, a health policy bombshell has burst in the Sunday press. The Swiss Medical Board questions systematic breast screening. As was to be expected, the tsunami of outrage arrived on Monday. Apparently, not all interested parties evaluate the same studies or interpret them differently.

What is the “number needed to screen” and the “number needed to hurt”? How many mammograms of what quality must be performed in how many women at what intervals to prevent a woman from dying from breast cancer? Does the interpretation and selection of studies depend on whether the experts’ primary goal is to reduce costs or to prevent as many women as possible from dying of breast cancer? How many women are unnecessarily confused by false positive results? In how many women is carcinoma missed despite the screening program? How many women may be made unnecessarily uncomfortable in order to provide relief to how many women? Is the pretest probability sufficiently high in the group of 50- to 69-year-old women? These questions can obviously be argued about!

The experts argue in public about an emotionally charged topic, and the layman wonders. On the Monday after the publication of the report at 09:00, the first patient already approaches me about the newspaper reports. She said she was upset and unsettled. She says her sister was diagnosed with breast cancer ten years ago at the age of 50 and to date has had no recurrence. Two years ago, she, my now 69-year-old patient, had her annual checkup with a new gynecologist. She had a guilty conscience because she had not had a mammogram for two years. It had been drilled into her that she needed to have annual mammograms. The visit to the gynecologist was very disappointing. The examination had been limited to taking the cancer smear. She had not had to remove her blouse and her breasts had not been examined. For this, she was registered at the hospital for a mammogram. Until today, she had not been under control and she would be grateful if I would recommend another doctor to her.

The public campaigns, discussions and policies cannot do justice to the individual woman. They promote uncertainty. Thus, one woman is afraid of missing a tumor, another of being unnecessarily upset and needlessly made ill.

You, dear colleagues, have the task of advising each individual woman, examining her carefully and taking the measures that meet her needs. You cannot escape this responsibility, now even more so when the experts are arguing.

Cordially, your

Josef Widler, MD

HAUSARZT PRAXIS 2014; 9(2): 1

Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Breast Cancer
  • Carcinoma
  • Costs
  • gynecologist
  • gynecologist
  • Mamma Screening
  • mammography
  • Recurrence
  • swiss medical board
Previous Article
  • Successful therapy of pAVD with EGb 761®.

Clinical studies document the efficacy of Ginkgo biloba extract

  • Angiology
  • Cardiology
  • News
  • RX
View Post
Next Article
  • Diabetes mellitus

First Google medical product in development

  • Endocrinology and Diabetology
  • News
  • Prevention and health care
  • RX
View Post
You May Also Like
View Post
  • 7 min
  • Rare diseases

Yellow nail and Swyer-James syndrome

    • CME continuing education
    • Dermatology and venereology
    • General Internal Medicine
    • Infectiology
    • Pneumology
    • RX
View Post
  • 6 min
  • Results of a systematic review and meta-analysis

Physical activity as a therapeutic approach for depression and anxiety disorders

    • Education
    • Psychiatry and psychotherapy
    • RX
    • Sports Medicine
    • Studies
View Post
  • 5 min
  • Underestimated risk - findings from a US cohort

Heart failure after myocardial infarction

    • Cardiology
    • Education
    • RX
    • Studies
View Post
  • 20 min
  • AI in neurology

Control instead of a flood of data: AI makes big data and wearables usable

    • Cardiology
    • CME continuing education
    • General Internal Medicine
    • Neurology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 4 min
  • From symptom to diagnosis

Abdominal pain – Sprue

    • Cases
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • Radiology
    • RX
View Post
  • 4 min
  • Case Report

76-year-old patient with pustular skin rash

    • Cases
    • Dermatology and venereology
    • Education
    • Oncology
    • RX
View Post
  • 3 min
  • Sponsored Content: Psoriasis

Dauerhafte Erscheinungsfreiheit auch bei betroffenen speziellen Hautarealen

    • Dermatology and venereology
    • Partner Content
    • Pharmacology and toxicology
    • Rheumatology
    • RX
    • Studies
View Post
  • 5 min
  • Antithymocyte globulin in children with T1D

Old medicine, new hope

    • Congress Reports
    • Pediatrics
    • Pharmacology and toxicology
    • RX
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Control instead of a flood of data: AI makes big data and wearables usable
  • 2
    Causes and prevention at work
  • 3
    Yellow nail and Swyer-James syndrome
  • 4
    Recommendations for action in practice
  • 5
    From the β-cell to the center: the versatile role of amylin

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.